Cargando…

Pretreatment (18)F-FDG PET/CT Imaging Predicts the KRAS/NRAS/BRAF Gene Mutational Status in Colorectal Cancer

OBJECTIVE: To investigate the association between KRAS/NRAS/BRAF mutations and metabolic parameters of pretreatment (18)F-FDG PET/CT in colorectal cancer (CRC). METHODS: A total of 85 patients with CRC were included in the study. PET/CT was performed in all the patients before surgery. The histopath...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Peng, Zou, Yuan, Qiu, Jia, Yang, Tianhong, Peng, Lei, Zhang, Xiangsong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233098/ https://www.ncbi.nlm.nih.gov/pubmed/34239564 http://dx.doi.org/10.1155/2021/6687291

Ejemplares similares

The Prognostic Value of (18)F-FDG PET/CT and KRAS Mutation in Colorectal Cancers
por: Arslan, Esra, et al.
Publicado: (2020)

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer
por: Gökmen, İvo, et al.
Publicado: (2023)

Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients
por: Hsu, Hung-Chih, et al.
Publicado: (2016)

KRAS/NRAS/BRAF Mutation Rate in Saudi Academic Hospital Patients With Colorectal Cancer
por: Saharti, Samah
Publicado: (2022)

High prevalence of unusual KRAS, NRAS, and BRAF mutations in POLE ‐ hypermutated colorectal cancers
por: Favre, Loetitia, et al.
Publicado: (2022)

KRAS, NRAS, BRAF signatures, and MMR status in colorectal cancer patients in North China
por: Lian, Shen-Yi, et al.
Publicado: (2023)

KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma
por: Pasca, Sergiu, et al.
Publicado: (2019)

Comparison of diagnostic efficacy of (18)F-FDG PET/CT and (68)Ga-DOTANOC PET/CT in ectopic adrenocorticotropic hormone syndrome
por: Zhang, Bing, et al.
Publicado: (2022)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

The significance of (18)F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis
por: Zhang, Li-Juan, et al.
Publicado: (2012)

KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study
por: Negru, Serban, et al.
Publicado: (2014)

Mutation Status and Immunohistochemical Correlation of KRAS, NRAS, and BRAF in 260 Chinese Colorectal and Gastric Cancers
por: Yang, Qiwei, et al.
Publicado: (2018)

A Diagnostic Nomogram Based on (18)F-FDG PET/CT for Bone Metastasis of Gastric Cancer
por: Wu, Chunhui, et al.
Publicado: (2021)

KRAS mutation effects on the 2-[18F]FDG PET uptake of colorectal adenocarcinoma metastases in the liver
por: Popovic, M., et al.
Publicado: (2020)

The Efficacy of Pretreatment (18)F-FDG PET-CT-Based Deep Learning Network Structure to Predict Survival in Nasopharyngeal Carcinoma
por: Long, Zi-chan, et al.
Publicado: (2023)

Prognostic Impact of Pretreatment 2-[(18)F]-FDG PET/CT Parameters in Primary Gastric DLBCL
por: Albano, Domenico, et al.
Publicado: (2021)

Role of 18F-FDG PET/CT in the Follow-up of Colorectal Cancer
por: Milardovic, Renata, et al.
Publicado: (2020)

Tailoring the clinical management of colorectal cancer by (18)F-FDG PET/CT
por: Shi, Yang, et al.
Publicado: (2022)

Correlation of EGFR or KRAS mutation status with (18)F-FDG uptake on PET-CT scan in lung adenocarcinoma
por: Takamochi, Kazuya, et al.
Publicado: (2017)

KRAS, NRAS, BRAF, HER2 and Microsatellite Instability in Metastatic Colorectal Cancer – Practical Implications for the Clinician
por: Afrăsânie, Vlad-Adrian, et al.
Publicado: (2019)

Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
por: Bożyk, Aleksandra, et al.
Publicado: (2021)

KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas
por: Martianov, Aleksandr S., et al.
Publicado: (2023)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

18F-FDG PET/CT and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

[18F]FDG PET/CT versus [18F]FDG PET/MRI for the diagnosis of colorectal liver metastasis: A systematic review and meta-analysis
por: Miao, Zhi, et al.
Publicado: (2023)

The prognostic value of (18)F-FDG PET/CT intra-tumoural metabolic heterogeneity in pretreatment neuroblastoma patients
por: Liu, Jun, et al.
Publicado: (2022)

PET-CT for Evaluation of Spleen and Liver (18)F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma
por: Rao, Liangjun, et al.
Publicado: (2016)

Relationship between [(18)F]FDG PET/CT and metabolomics in patients with colorectal cancer
por: Imajo, Masashi, et al.
Publicado: (2022)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Frequency of NRAS Gene Mutation in Wild Type KRAS and BRAF Colorectal Cancers; a Single Center Study
por: Momenzadeh, Hooria, et al.
Publicado: (2018)

Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer
por: Franczak, Claire, et al.
Publicado: (2020)

Differentiation of suprasellar meningiomas from non-functioning pituitary macroadenomas by (18)F-FDG and (13)N-Ammonia PET/CT
por: Ding, Lei, et al.
Publicado: (2020)

Construction of a reference material panel for detecting KRAS/NRAS/EGFR/BRAF/MET mutations in plasma ctDNA
por: Xu, Jun, et al.
Publicado: (2021)

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
por: Allahqoli, Leila, et al.
Publicado: (2023)

Crossed cerebellar diaschisis on F-18 FDG PET/CT
por: Agrawal, Kanhaiya Lal, et al.
Publicado: (2011)

Peritoneal Mouse as Detected on (18)F-FDG PET-CT
por: Allam, Talha, et al.
Publicado: (2013)

(18)F-FDG PET-CT for Staging of Conjunctival Melanoma
por: Damian, Andres, et al.
Publicado: (2013)

(18)F-FDG PET/CT in Pleural Epithelioid Hemangioendothelioma
por: Albano, Domenico, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3l6vll5pod0tfqf6stgg1ejes0